Table II.

The frequency of EBV epitope-specific CTL in peripheral blood

DonorEBV EpitopeLDAaELISPOTaTetramerab
CHB8 RAKFKQLL601,0202,605 (1.0%)
B8 FLRGRAYGL21121230 (0.1%)
PAB8 RAKFKQLL125295177 (0.1%)
B8 FLRGRAYGLUndetectableUndetectableUndetectable
B7 RPPIFIRRL20165ND
JBB8 RAKFKQLLNDc7507,000 (5.0%)
B8 FLRGRAYGLND4802,900 (2.0%)
ARB8 RAKFKQLLND2501,600 (0.5%)
B8 FLRGRAYGLND4602,100 (0.7%)
CMB8 RAKFKQLL7252,3006,200 (4.3%)
B8 FLRGRAYGLUndetectable10Undetectable
A11 IVTDFSVIK2408104,760 (3.3%)
A11 AVFDRKSDAK25400ND
DMB8 RAKFKQLLND2,50011,400 (5.5%)
B8 FLRGRAYGLND20Undetectable
A11 IVTDFSVIK1701,0005,000 (3.8%)
A11 AVFDRKSDAK10120ND
LUB8 RAKFKQLL60350ND
B8 FLRGRAYGL40165ND
A2 GLCTLVAML15t 25ND
JSA2 GLCTLVAML1307102,900 (0.8%)
VNA2 GLCTLVAML3807102,600 (1.1%)
A2 SVRDRLARLND95ND
ROA2 GLCTLVAML1015Undetectable
A2 SVRDRLARLND10ND
B7 RPPIFIRRL175430ND
LCA2 GLCTLVAML135360920 (0.4%)
A11 IVTDFSVIKUndetectableUndetectableND
DAA11 IVTDFSVIKND5002,000 (1.6%)
A11 AVFDRKSDAKND50ND
PBA11 IVTDFSVIK403001,800 (0.7%)
A11 AVFDRKSDAKUndetectable70ND
  • a Values are given per 106 PBMC.

  • b Values in parentheses are given as % CD8+ T cells.

  • c ND, not determined.